Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 138

1.

Stool microbiome reveals diverse bacterial ureases as confounders of oral urea breath testing for Helicobacter pylori and Mycobacterium tuberculosis in Bamako, Mali.

Maiga M, Cohen K, Baya B, Srikrishna G, Siddiqui S, Sanogo M, Somboro AM, Diarra B, Diallo MH, Mazumdar V, Yoder C, Orsega S, Belson M, Kassambara H, Goita D, Murphy RL, Dao S, Polis M, Diallo S, Timmins GS, Dodd L, Earl AM, Bishai WR.

J Breath Res. 2016 Aug 17;10(3):036012. doi: 10.1088/1752-7155/10/3/036012.

PMID:
27532494
2.

Molecular identification of Mycobacterium bovis from cattle and human host in Mali: expanded genetic diversity.

Diallo M, Diarra B, Sanogo M, Togo AC, Somboro AM, Diallo MH, Traoré B, Maiga M, Koné Y, Tounkara K, Sarro YD, Baya B, Goita D, Kassambara H, Dembélé BP, Siddiqui S, Murphy RL, Dao S, Diallo S, Tounkara A, Niang M.

BMC Vet Res. 2016 Jul 20;12(1):145. doi: 10.1186/s12917-016-0768-7.

3.

Nontuberculous Mycobacteria Isolated from Tuberculosis Suspects in Ibadan, Nigeria.

Cadmus SI, Diarra B, Traore B, Maiga M, Siddiqui S, Tounkara A, Falodun O, Lawal W, Adewole IF, Murphy R, van Soolingen D, Taiwo B.

J Pathog. 2016;2016:6547363. doi: 10.1155/2016/6547363. Epub 2016 Mar 23.

4.

Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries.

Charles MK, Lindegren ML, Wester CW, Blevins M, Sterling TR, Dung NT, Dusingize JC, Avit-Edi D, Durier N, Castelnuovo B, Nakigozi G, Cortes CP, Ballif M, Fenner L; International epidemiology Databases to Evaluate AIDS (IeDEA) Collaboration.

PLoS One. 2016 Apr 13;11(4):e0153243. doi: 10.1371/journal.pone.0153243. eCollection 2016.

5.

Erratum to "Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis" [EBioMedicine 2 (8), August 2015, 868-873].

Maiga M, Ahidjo BA, Maiga MC, Cheung L, Pelly S, Lun S, Bougoudogo F, Bishai WR.

EBioMedicine. 2015 Oct 19;2(11):1834. doi: 10.1016/j.ebiom.2015.10.019. eCollection 2015 Nov. No abstract available.

6.

Immunologic response in treatment-naïve HIV-2-infected patients: the IeDEA West Africa cohort.

Balestre E, Ekouevi DK, Tchounga B, Eholie SP, Messou E, Sawadogo A, Thiébaut R, May MT, Sterne JA, Dabis F; International Epidemiological Database to Evaluate AIDS (IeDEA) West Africa Collaboration.

J Int AIDS Soc. 2016 Feb 8;19(1):20044. doi: 10.7448/IAS.19.1.20044. eCollection 2016.

7.

Whole Genome Sequencing of Mycobacterium africanum Strains from Mali Provides Insights into the Mechanisms of Geographic Restriction.

Winglee K, Manson McGuire A, Maiga M, Abeel T, Shea T, Desjardins CA, Diarra B, Baya B, Sanogo M, Diallo S, Earl AM, Bishai WR.

PLoS Negl Trop Dis. 2016 Jan 11;10(1):e0004332. doi: 10.1371/journal.pntd.0004332. eCollection 2016 Jan.

8.

APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso.

Compaore TR, Soubeiga ST, Ouattara AK, Obiri-Yeboah D, Tchelougou D, Maiga M, Assih M, Bisseye C, Bakouan D, Compaore IP, Dembele A, Martinson J, Simpore J.

PLoS One. 2016 Jan 7;11(1):e0146386. doi: 10.1371/journal.pone.0146386. eCollection 2016.

9.

Roflumilast, a Type 4 Phosphodiesterase Inhibitor, Shows Promising Adjunctive, Host-Directed Therapeutic Activity in a Mouse Model of Tuberculosis.

Maiga MC, Ahidjo BA, Maiga M, Bishai WR.

Antimicrob Agents Chemother. 2015 Dec;59(12):7888-90. doi: 10.1128/AAC.02145-15. Epub 2015 Oct 5.

10.

Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis.

Maiga M, Ahidjo BA, Maiga MC, Cheung L, Pelly S, Lun S, Bougoudogo F, Bishai WR.

EBioMedicine. 2015 Jul 14;2(8):868-73. doi: 10.1016/j.ebiom.2015.07.014. eCollection 2015 Aug. Erratum in: EBioMedicine. 2015 Nov;2(11):1834.

11.

Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.

Haas AD, Keiser O, Balestre E, Brown S, Bissagnene E, Chimbetete C, Dabis F, Davies MA, Hoffmann CJ, Oyaro P, Parkes-Ratanshi R, Reynolds SJ, Sikazwe I, Wools-Kaloustian K, Zannou DM, Wandeler G, Egger M; IeDEA southern Africa, east Africa, and west Africa.

Lancet HIV. 2015 Jul;2(7):e271-8. doi: 10.1016/S2352-3018(15)00087-9. Epub 2015 Jun 16.

12.

Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: a prospective cohort study.

Harouna AM, Amorissani-Folquet M, Eboua FT, Desmonde S, N'Gbeche S, Aka EA, Kouadio K, Kouacou B, Malateste K, Bosse-Amani C, Ahuatchi Coffie P, Leroy V; IeDEA paediatric West African Study Group.

BMC Infect Dis. 2015 Aug 7;15:317. doi: 10.1186/s12879-015-1009-6.

13.

Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.

Desmonde S, Eboua FT, Malateste K, Dicko F, Ekouévi DK, Ngbeché S, Koueta F, Sy HS, Renner L, Koumakpai SA, Leroy V; IeDEA Pediatric West African Working Group.

AIDS. 2015 Jul 31;29(12):1527-36. doi: 10.1097/QAD.0000000000000707.

PMID:
26244392
14.

Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort.

Jesson J, Koumakpaï S, Diagne NR, Amorissani-Folquet M, Kouéta F, Aka A, Lawson-Evi K, Dicko F, Kouakou K, Pety T, Renner L, Eboua T, Coffie PA, Desmonde S, Leroy V; Paediatric WADA IeDEA Collaboration.

Pediatr Infect Dis J. 2015 Jul;34(7):e159-68. doi: 10.1097/INF.0000000000000734.

15.

Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali.

Traoré F, Gormally E, Villar S, Friesen MD, Groopman JD, Vernet G, Diallo S, Hainaut P, Maiga MY.

BMC Infect Dis. 2015 Apr 11;15:180. doi: 10.1186/s12879-015-0916-x.

16.

Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.

Duda SN, Farr AM, Lindegren ML, Blevins M, Wester CW, Wools-Kaloustian K, Ekouevi DK, Egger M, Hemingway-Foday J, Cooper DA, Moore RD, McGowan CC, Nash D; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.

J Int AIDS Soc. 2014 Dec 15;17:19045. doi: 10.7448/IAS.17.1.19045. eCollection 2014.

17.

Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test.

Choi SW, Maiga M, Maiga MC, Atudorei V, Sharp ZD, Bishai WR, Timmins GS.

Nat Commun. 2014 Sep 23;5:4989. doi: 10.1038/ncomms5989.

18.

Synthetic lethality reveals mechanisms of Mycobacterium tuberculosis resistance to β-lactams.

Lun S, Miranda D, Kubler A, Guo H, Maiga MC, Winglee K, Pelly S, Bishai WR.

MBio. 2014 Sep 16;5(5):e01767-14. doi: 10.1128/mBio.01767-14.

19.

Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.

Ndondoki C, Dicko F, Ahuatchi Coffie P, Kassi Eboua T, Ekouevi DK, Kouadio K, Edmond Aka A, Malateste K, Dabis F, Amani-Bosse C, Toure P, Leroy V; Paediatric IeDEA West African Working Group.

J Int AIDS Soc. 2014 Jun 2;17:18737. doi: 10.7448/IAS.17.1.18737. eCollection 2014.

20.

Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children.

Desmonde S, Dicko F, Koueta F, Eboua T, Balestre E, Amani-Bosse C, Aka EA, Lawson-Evi K, Amorissani-Folquet M, Kouakou K, Koumakpai S, Renner L, Signaté Sy H, Leroy V; IeDEA West Africa Paediatric Collaboration.

AIDS. 2014 Jul 17;28(11):1645-55. doi: 10.1097/QAD.0000000000000272.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk